News3 mins ago
SK pharmteco doubles viral vector production capacity in Europe
Yposkesi, SK pharmteco’s clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes its second bioproduction facility and doubles its manufacturing footprint...
